Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 12 Jun 2026 for Arcus Biosciences, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Andrew J. Perlman: trading record in brief
Andrew J. Perlman is a declared insider of Arcus Biosciences, Inc. (board member), with filings sourced from SEC (Form 4). We count 6 filings; the first trade dates from 3 June 2021 and the latest from 11 June 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 12 June 2026, reports a share grant in Arcus Biosciences, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Andrew J. Perlman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
5,700 sharesCommon StockSEC:0001201617-26-000003:0
13,300 shares0Common StockSEC:0001724521-25-000092:0
8,400 shares0Common StockSEC:0001724521-24-000112:0
6,800 shares0Common StockSEC:0001209191-23-038148:0
4,100 shares0Common StockSEC:0001209191-22-037438:0
3,000 shares0Common StockSEC:0001209191-21-038635:0
6 of 6 declarations
